ClouDr Group's revenue for the
six
months ended in Dec. 2023 was HK$2,065 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4,037 Mil.
ClouDr Group's Revenue per Share for the
six
months ended in Dec. 2023 was HK$3.76.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$7.46.
Warning Sign:
ClouDr Group Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of ClouDr Group was -32.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 62.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 5 years, ClouDr Group's highest 3-Year average Revenue per Share Growth Rate was 121.20% per year. The lowest was 62.10% per year. And the median was 91.65% per year.
ClouDr Group Revenue Historical Data
The historical data trend for ClouDr Group's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, ClouDr Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClouDr Group's Revenue Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ClouDr Group's Revenue distribution charts can be found below:
* The bar in red indicates where ClouDr Group's Revenue falls into.
ClouDr Group Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$4,037 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClouDr Group (HKSE:09955) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
ClouDr Group Revenue Related Terms
Thank you for viewing the detailed overview of ClouDr Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09955 has been successfully added to your